CLINICAL_TRIALS
trial_result
· 2014-12-10
Clinical Trial Update: A Study of Dose Titration of LY2189265 in Overweight Participants With Type 2 Diabetes Mellitus [Phase 2]
Summary
This document reports the results of a Phase 2 dose-titration study of LY2189265 in overweight adults with Type 2 diabetes mellitus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2014-12-10